Postherpetic neuralgia: The never-ending challenge

Pain Practice

Volumn 5, Issue 4, 2005, Pages 327-340

  Niv, David ^a   Maltsman Tseikhin, Alexander ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Acute herpes zoster; Pain management; Postherpetic neuralgia

Indexed keywords

ACETYLSALICYLIC ACID; ACICLOVIR; ALPHA TOCOPHEROL; AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIVIRUS AGENT; BENZODIAZEPINE DERIVATIVE; CAPSAICIN; CARBAMAZEPINE; CLOMIPRAMINE; CLONAZEPAM; CORTICOSTEROID; DESIPRAMINE; DICLOFENAC; EMLA; FLUPHENAZINE; GABAPENTIN; INDOMETACIN; KETAMINE; LIDOCAINE; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT; OPIATE; PREGABALIN; PRILOCAINE; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VALPROIC ACID;

ACUPUNCTURE; ANXIETY; BURNING SENSATION; CENTRAL NERVOUS SYSTEM DEPRESSION; CHRONIC PAIN; CLINICAL TRIAL; DIZZINESS; DOSE RESPONSE; DRUG ABSORPTION; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; DRUG TOLERABILITY; FATIGUE; HERPES ZOSTER; HUMAN; LOUDNESS RECRUITMENT; MENINGITIS; MULTICENTER STUDY; NERVE BLOCK; NERVE DEGENERATION; NEURITIS; POSTHERPETIC NEURALGIA; PRURITUS; RADICULAR PAIN; REVIEW; SIDE EFFECT; TRANSCUTANEOUS NERVE STIMULATION; VARICELLA ZOSTER VIRUS;

EID: 29144521550     PISSN: 15307085     EISSN: 15332500     Source Type: Journal    
DOI: 10.1111/j.1533-2500.2005.00035.x     Document Type: Review

References (169)

1. Bokai J. Das Auftreten der Schafblattern unter be sonderen Umstanden. Ungar Arch Med. 1892;1:159-161.
2. Hope-Simpson RE. The nature of herpes zoster: a long term study and a new hypothesis. Proc R Soc Med. 1965;58:9-20.
3. Mauskopf JA, Austin R, Dix LP, Berzon RA. Estimating the value of a generic quality-of-life measure. Med Care. 1995;33(suppl 4):AS195-AS202.
4. Burgoon CF, Burgoon JS, Baldridge GD. The natural history of herpes zoster. JAMA. 1957;164:265-269.
5. Weis O, Swiratanakul K, Weintraub M. Treatment of post herpetic neuralgia and acute herpetic pain with amitriptyline and prophenazine. S Afr Med J. 1982;62:274-275.
6. Ragozzino MW, Meltron LJ, Kurland LT, et al. Risk of cancer after herpes zoster: a population based study. N Engl J Med. 1982;307:393-397.
7. Ragozzino MW, Meltron LJ, Kurland LT, et al. Population based study of herpes zoster and its sequelae. Medicine (Baltimore). 1982;61:310-316.
8. De Moragas JM, Kierland RR. The outcome of patients with herpes zoster. Arch Dermatol. 1957;75:193-196.
9. Hope-Simpson RE. Postherpetic neuralgia. J R Coll Gen Pract. 1975;25:571-575.
10. Molin L. Aspects of the natural history of herpes zoster. A follow-up investigation of outpatient material. Acta Derm Venereol. 1969;49:569-583.
11. Rogers RS 3rd, Tindall JP. Geriatric herpes zoster. J Am Geriair Soc. 1971;19:495-504.
12. Higa K, Mori M, Hirata K, et al. Severity of skin lesions of herpes zoster at the worst phase rather than age and involved region most influences the duration of acute herpetic pain. Pain. 1997;69:245-253.
13. Dworkin RH, Perkins FM, Nagasako EM. Prospects for the prevention of postherpetic neuralgia in herpes zoster patients. Clin J Pain. 2000;16:S90-S100.
14. Haanpaa M, Laippala P, Nurmikko T. Pain and somatosensory dysfunction in acute herpes zoster. Clin J Pain. 1999;15:50-58.
15. Decroix J, Partsh H, Gonzalez R, et al. Factors influencing pain outcome in herpes zoster observational study with valaciclovir. J Eur Acad Dermatol Venereol. 2000;14:22-33.
16. Cupps TR, Silverman GJ, Fauci AS. Herpes zoster in patients with treated Wegener's Granulomatosis. A possible role for cyclophosphamide. Am J Med. 1980;69:881-885.
17. Feld R, Evans WK, De Boer G. Herpes zoster in patients with small cell carcinoma of the lung receiving combined modality treatment. Ann Intern Med. 1980;93:282-283.
18. Mazur M, Dolin R. Herpes zoster at the NIH: a 20 year experience. Am J Med. 1978;65:738-744.
19. McKendell RR, Klawans HI. Nervous system complications of varicella zoster virus. In: Vikken PJ, Bruyn GW, eds. Handbook of Clinical Neurology. Amsterdam: North Holland; 1978:161-183.
20. Moutsopoulos HM, Gallagher JD, Decker JI, et al. Herpes zoster in patients with systemic lupus erythematosus. Arthritis Rheum. 1978;21:798-802.
21. Rifkind D. The activation of varicella zoster virus infection by immunosuppressive therapy. J Lab Clin Med. 1966;68:463-474.
22. Schimpff S, Serpick A, Stoler B, et al. Varicella zoster infections in patients with cancer. Ann Intern Med. 1972;76:241-254.
23. Boon R. Efficacy and Safety of Famcyclovir in the Treatment of Herpes Zoster. 2nd International Conference on the Varicella Zoster Virus, Paris: 1995.
24. Brown GR. Herpes zoster: correlation of age, sex, distribution and associated disorders. South Med J. 1976;69:576-578.
25. McCulloch DK, Fraser DM, Duncan LP. Shingles in diabetes mellitus. Practitioner. 1982;226:531-532.
26. Schmader K, George LK, Burchett BM, et al. Race and stress in the incidence of herpes zoster in the elderly. J Am Geriatr Soc. 1998;46:973-977.
27. Watson CPN, Watt VR, Chipman M, et al. The prognosis with postherpetic neuralgia. Pain. 1991;46:195-199.
28. Eaglestein WH, Katz R, Brown JA. The effects of early corticosteroid therapy on the skin eruption and pain of herpes zoster. JAMA. 1970;211:1681-1683.
29. Riopelle JM, Naraghi M, Grush KP. Chronic neuralgia incidence following local anesthetic for herpes zoster therapy. Arch Dermatol. 1984;120:747-750.
30. Dworkin RH, Portenoy RK. Proposed classification of herpes zoster pain. Lancet. 1994;343:1648.
31. Desmond RA, Weiss HL, Arani RB, et al. Clinical applications for change-point analysis of herpes zoster pain. J Pain Symptom Manage. 2002;23:510-516.
32. Johnson RW, Dworkin RH. Treatment of herpes zoster and postherpetic neuralgia. BMJ. 2003;326:748-750.
33. Dworkin RH, Schmader KE. Epidemiology and natural history of herpes zoster and postherpetic neuralgia. In: Watson CPN, Gershon AA, eds. Herpes Zoster and Postherpetic Neuralgia. 2nd ed. New York: Elsevier Press; 2001:39-64.
34. Denny-Brown D, Adams RD, Fitzgerald PJ. Pathologic features of herpes zoster: a note on "geniculate" herpes. Arch Neurol Psychiat. 1944;51:216-231.
35. Head H, Campbell AW. The pathology of herpes zoster and its bearing on sensory localization. Brain. 1900;23:353-523.
36. Juel-Jensen BE, MacCallum FO. Herpes Simple Varicella and Zoster. Philadelphia, PA: Lippincott; 1972.
37. Smith FP. Pathological studies of spinal nerve ganglia in relation to intractable intercostals pain. Surg Neurol. 1978;10:50-53.
38. Esiri MM, Tomlinson AH. Herpes zoster. Demonstration of virus in trigeminal nerve and ganglion by immunofluorescence and electron microscopy. J Neurol Sci. 1972; 15:35-48.
39. Muller SA, Winkelmann RK. Cutaneous nerve changes in zoster. J Invest Dermatol. 1969;52:71-77.
40. Watson CPN, Deck JH, Morshead C, et al. Post-herpetic neuralgia: further post-mortem studies of cases with and without pain. Pain. 1991;44:105-117.
41. Noordenbos W. Problems pertaining to the transmission of nerve impulses which give rise to pain. Pain (Amsterdam). 1959;1:4-10, 68-80.
42. Melzack R, Wall PD. Pain mechanisms: a new theory. Science. 1965;1950:971-979.
43. Watson CPN, Morshead C, Van der Kooy D, et al. Post herpetic neuralgia: post-mortem analysis of a case. Pain. 1988;34:129-138.
44. Long DM. Pain of peripheral nerve injury. In: Youmans JR, ed. Neurological Surgery. Philadelphia, PA: Saunders; 1982:3641-3643.
45. Pappagallo M, Campbell JN. Chronic opioid therapy as alternative treatment for post-herpetic neuralgia. Ann Neurol. 1994;35(suppl):S54-S56.
46. Morris GC, Gibson SJ, Helme RD. Capsaicin-induced flare and vasodilatation in patients with post-herpetic neuralgia. Pain. 1995;63:93-101.
47. Mondelli M, Romano C, Della Porta P, et al. Electrophysiological findings in peripheral fibers of subjects with and without post-herpetic neuralgia. Electroencephalogr Clin Neurophysiol. 1996;101:185-191.
48. Rowbotham MC, Fields HL. The relationship of pain, allodynia and thermal sensation in post-herpetic neuralgia. Brain. 1996;119:347-354.
49. Choi B, Rowbotham MC. Effect of adrenergic receptor activation on post-herpetic neuralgia pain and sensory disturbances. Pain. 1997;69:55-63.
50. Baron R, Saguer M. Mechanical allodynia in post-herpetic neuralgia: evidence for central mechanisms depending on nociceptive C-fiber degeneration. Neurology. 1995;45:S63-S65.
51. Baron R, Saguer M. Postherpetic neuralgia. Are C-nociceptors involved in signaling and maintenance of tactile allodynia? Brain. 1993;116:1477-1496.
52. Abboh KH, Martin AD. Surgical treatment of postherpetic neuralgia by subdermal denervation. Neurology. 1951;1:275-282.
53. Bonica JJ. Herpes zoster and postherpetic neuralgia. The Management of Pain. 2nd ed. Vol. 1. Philadelphia, PA: Lea & Febiger; 1990:257-262.
54. Browder J, Deveer JA. Herpes zoster a surgical procedure for the treatment of postherpetic neuralgia. Ann Surg. 1949;130:622-636.
55. Combes FC, Canizares O, Simunagco S. Herpes zoster: treatment of pain. J Invest Dermatol. 1950;14:53-56.
56. Russel WR, Espir MLE, Morganstern FS. Treatment of postherpetic neuralgia. Lancet. 1957;1:242-245.
57. Appleman DH. Treatment of herpes zoster with ACTH. N Engl J Med. 1955;253:693-695.
58. Dubinsky RM, Kabbani H, El-Chami Z, Boutwell C, Ali H, et al. Practice parameter: treatment of postherpetic neuralgia. Neurology. 2004;63:959-965.
59. Raja SN, Haythornthwaite JA, Pappagallo M, et al. Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology. 2002;59:1015-1021.
60. Dworkin RH, Backonja M, Rowbotham MC, et al. Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch Neurol. 2003;60:1524-1534.
61. Walsh TD. Antidepressant in chronic pain. Clin Neuropharmacol. 1983;6:171-195.
62. Kost RG, Straus SE. Postherpetic neuralgia - pathogenesis, treatment and prevention. N Engl J Med. 1996;335:32-42.
63. Irani DN, Johnson RT. New approaches to the treatment of herpes zoster and post-herpetic neuralgia. Infectious Med. 1996;13:897-902.
64. Woodforde JM, Dwyer B, McEwen BW, et al. Treatment of post herpetic neuralgia. Med J Aust. 1965;2:869-872.
65. Kishore-Kumar R, Max MB, Schafer SC, et al. Desipramine relieves post herpetic neuralgia. Clin Pharmacol Ther. 1990;47:305-312.
66. Taub A. Relief of postherpetic neuralgia with psychotropic drugs. J Neurosurg. 1973;39:235-239.
67. Taub A, Collins WF. Observation on the treatment of degeneration of dysesthesia with psychotropic drugs. Adv Neurol. 1974;4:309-315.
68. Watson CPN, Evan RJ, Reed K, et al. Amitriptyline vs. placebo in postherpetic neuralgia. Neurology. 1982;32:671-673.
69. Watson CPN. Therapeutic window for amitriptyline analgesia. CMAJ. 1984;130:105-106.
70. Max MB, Schafer SC, Culnane M, et al. Amitriptyline, but not lorazepam, relieves post herpetic neuralgia. Neurology. 1988;38:1427-1432.
71. Hatangdi VS, Boss RA, Richards EG. Postherpetic neuralgia: management with antiepileptic and tricyclic drugs. In: Bonica JJ, Fessards A, eds. Advances in Pain Research and Therapy. New York: Raven Press; 1976:583-599.
72. Konduer R. Use of psychotropic drugs for the treatment of chronic severe pain. In: Bonica JJ, Fessards A, eds. Advances in Pain Research and Therapy. New York: Raven Press; 1976:579-582.
73. Carasso RL, Yehuda S, Strefler M. Clomipramine and amitriptyline in the treatment of severe pain. Int J Neurosci. 1979;9:191-194.
74. Crue BL, Todd EM, Moline DB. Post herpetic neuralgia conservative treatment regimen. In: Cure BL, ed. Pain Research and Treatment. New York: Academic Press; 1975:289-292.
75. Gerson GR, Jones RB, Luscombe DK. Studies on the concomitant use of carbamazepine and clomipramine for the relief of post herpetic neuralgia. Postgrad Med J. 1977; 53:104-109.
76. Raftery H. The management of post herpetic pain using sodium valproate and amitriptyline. Ir Med J. 1979;72:399-401.
77. Swerdlow M. Anticonvulsant drugs and chronic pain. Clin Neuropharmacol. 1982;7:51-82.
78. Swerland M. The treatment of shooting pain. Postgrad Med J. 1980;56:159-161.
79. Killian JM, Fromm JH. Carbamezepine for treatment of neuralgia. Lancet. 1957;1:242-245.
80. Niv D, Ben-Ari S, Rappoport A, et al. Post herpetic neuralgia - clinical experience with a conservative treatment. Clin J Pain. 1989;5:295-300.
81. Bennett MI, Simpson KH. Gabapentin in the treatment of neuropathic pain. Palliat Med. 2004;18:5-11.
82. Rowbotham MC, Hardeb N, Stacey B, et al. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA. 1998;280:1837-1842.
83. Watson CPN. The medical treatment of postherpetic neuralgia: antidepressants, anticonvulsants, opioids and practical guidelines for management. In: Watson CPN, Gershon AA, eds. Herpes Zoster and Postherpetic Neuralgia. 2nd ed. New York: Elsevier Press; 2001:243-254.
84. Singh D, Kennedy DH. The use of gabapentin for the treatment of postherpetic neuralgia. Clin Ther. 2003;25:852-889.
85. Rowbotham MC, Harden N, Stacey B, et al. Gabapentin for the treatment of postherpetic neuralgia. JAMA. 1998;280:1837-1842.
86. Wetzel CH, Connelly JF. Use of gabapentin in pain management. Ann Pharmacother. 1997;31:1082-1083.
87. Pappagallo M, Haldey EJ. Pharmacological management of postherpetic neuralgia. CNS Drugs. 2003;17:771-780.
88. Dworkin RH, Corbin AE, Young JP Jr, et al. Pregabalin for the treatment of postherpetic neuralgia: randomized, placebo-controlled trial. Neurology. 2003;60:1274-1283.
89. Rowbotham M, Young JP, Sharma U. Pregabalin reduces neuropathic pain associated with diabetic peripheral neuropathy or postherpetic neuralgia by 3rd day of treatment. Pain Practice 2004; Book of abstracts 3rd World Congress, WIP, 271.
90. Niv D, Maltsman-Tseikhin A, Lang E. Postherpetic neuralgia: what do we know and where are we heading? Pain Physician. 2004;7:239-247.
91. McQuay HJ, Carroll D, Jadad AR, et al. Anticonvulsant drugs for management of pain: a systematic review. BMJ. 1995;311:1047-1052.
92. Rains C, Bryson HM. Topical capsaicin. A review of its pharmacological properties and therapeutic potential in post herpetic neuralgia, diabetic neuropathy, and osteoarthritis. Drugs Aging. 1995;7:317-328.
93. Litman SJ, Vitkun SA, Poppers RJ. Use of EMLA cream in the treatment of post-herpetic neuralgia. J Clin Anesth. 1996;8:54-57.
94. De Benedittis G, Besana F, Lorenzetti A. A new topical treatment for acute herpetic neuralgia and post-herpetic neuralgia: the aspirin/diethyl ether mixture. An open-label study plus a double-blind controlled clinical trial. Pain. 1992;48:383-390.
95. De Benedittis G, Lorenzetti A. Topical aspirin/diethyl ether mixture versus indomethacin and diclofenac/diethyl ether mixtures for acute herpetic neuralgia and postherpetic neuralgia: a double-blind crossover placebo-controlled study. Pain. 1996;65:45-51.
96. Sokolowski P. Capsaicin in pain therapy. Wiad Lek. 1994;47:527-532.
97. Rowbotham MC, Davies PS, Fields HL. Topical lidocaine gel relieves postherpetic neuralgia. Ann Neurol. 1995;37:246-253.
98. Rowbotham MC, Davies PS, Verkempinck C, et al. Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia. Pain. 1996;65:39-44.
99. Jessell TM, Iverson LL, Cuello AC. Capsaicin induced depletion of substance P from primary sensory neurons. Brain Res. 1978;152:132-188.
100. Otsuka M, Konishi S. Release of substance P-like immunoreactivity from isolated spinal cord of newborn rat. Nature. 1976;264:83-84.
101. Watson N, Evans RJ, Watt VR, et al. Post herpetic neuralgia and topical capsaicin. Pain. 1988;33:333-340.
102. Stow PJ, Glynn CJ, Minor B. EMLA cream in the treatment of post-herpetic neuralgia. Efficacy and pharmacokinetic profile. Pain. 1989;39:301-305.
103. Schwartz S, Singer R, Rowe D, et al. High-strength capsaicin cream 0.25% in a lidocaine-containing vehicle is a safe and effective adjunctive treatment for painful diabetic neuropathy or postherpetic neuralgia. J Neuropathic Pain Symptom Palliation. 2005;1:69-76.
104. King RB. Topical aspirin in chloroform and the relief of pain due to herpes zoster and postherpetic neuralgia. Arch Neurol. 1993;50:1046-1053.
105. Portenoy RK, Foley KM, Inturrisi CE. The nature of opioid responsiveness and its implications for neuropathic pain: new hypotheses derived from studies of opioid infusions. Pain. 1990;43:273-286.
106. Portenoy RK. Chronic opioid therapy in non-malignant pain. J Pain Symptom Manage. 1990;5:46-62.
107. Zenz M, Strumpf M, Tryba M. Long-term oral opioid therapy in patients with non-malignant pain. J Pain Symptom Manage. 1992;7:67-77.
108. Watson CPN, Babul N. Oxycodone relieves neuropathic pain: a randomized trial in postherpetic neuralgia. Neurology. 1998;50:1837-1841.
109. Portenoy RK. Opioid therapy for chronic nonmalignant pain: a review of the critical issues. J Pain Symptom Manage. 1996;11:203-217.
110. Hill CS. The barriers to adequate pain management with opioid analgesics. Semin Oncol. 1993;20:1-5.
111. Vielvoye-Kerkmeer A, Theuvenet PJ. Misconceptions about opioid addiction. Paineurope. 2003;1:6-7.
112. Jamison R, Schein JR, Vallow S, et al. Neuropsychological effects of long-term opioid use in chronic pain patients. J Pain Symptom Manage. 2003;26:913-921.
113. Rowbotham MC, Twilling L, Davies PS, et al. Oral opioid therapy for chronic peripheral and central neuropathic pain. N Engl J Med. 2003;348:1223-1232.
114. Taub A. Opioid analgesics in the treatment of chronic intractable pain of non-neoplastic origin. In: Kitahata LM, Collins D, eds. Narcotic Analgesics in Anaesthesiology. Baltimore, MD: Williams & Wilkins; 1982:199-208.
115. Watson CPN, Evans RJ, Watt VR, et al. Postherpetic neuralgia: 208 cases. Pain. 1988;35:289-297.
116. Raja SN, Haythornthwaite JA. Combination therapy for neuropathic pain - which drugs, which combination, which patients? N Engl J Med. 2005;352:1373-1375.
117. Gilron I, Bailey JM, Tu D, Holden RR, Weaver DF, Houlden RL. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med. 2005;352:1324-1334.
118. Boureau F, Legallicier P, Kabir-Ahmadi M. Tramadol in post-herpetic neuralgia: a randomized, double-blind, placebo-controlled trial. Pain. 2003;104:323-331.
119. Ayres S, Mihan R. Letter: post-herpes zoster neuralgia: response to vitamin E therapy. Arch Dermatol. 1973;108:855-856.
120. Moore KC. Laser Therapy in Post Herpetic Neuralgia. Presented to the British Medical Laser Association "241" Workshop and AGM, The Royal London Hospital, 1996.
121. Yaksich I, Tan LC, Previn V. Low energy laser therapy for treatment of post-herpetic neuralgia. Ann Acad Med Singapore. 1993;22:441-442.
122. Kageshima K, Wakasugi B, Shiotani M, et al. Thoracic and lumbar sympathetic ganglion block for post herpetic neuralgia. Masui. 1992;41:106-110.
123. Perkins HM, Hanlon PR. Epidural injections of local anesthetics and steroids for the relief of pain secondary to herpes zoster. Arch Surg. 1978;113:253-254.
124. Colding A. Treatment of shingles (herpes zoster) with sympathetic blocking. Sygeplejersken. 1972;72:8-10.
125. Colding A. Treatment of pain: organization of pain clinic treatment of acute herpes zoster. Proc R Soc Lond. 1973;66:541-543.
126. Masud KZ, Forster KJ. Sympathetic block in herpes zoster. Am Fam Physician. 1975;12:142-143.
127. Forrest JB. Management of chronic dorsal root pain with epidural steroid. Can Anaesth Soc J. 1978;25:218-225.
128. Epstein E. Treatment of zoster and postzoster neuralgia by the intralesional injection of triamcinolone: a computer analysis of 199 cases. Int J Dermat. 1976;15:762-769.
129. Epstein E. Triamcinolone-procaine in the treatment of zoster and post zoster neuralgia. Calif Med. 1971;115:6-10.
130. Tio R, Moya F, Vorasaran S. Treatments of post herpetic neuralgia. Anesth Sinica. 1978;16:151-153.
131. Eide K, Stubhaug A, Oye I, Breivik H. Continuous subcutaneous administration of the N-methyl-D-aspartic acid (NMDA) receptor antagonist ketamine in the treatment of post-herpetic neuralgia. Pain. 1995;61:221-228.
132. Eide PK, Jorum E, Stubhaug A, et al. Relief of post-herpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine: a double-blind, cross-over comparison with morphine and placebo. Pain. 1994;58:347-354.
133. Suzuki T, Kato J, Sacki S, et al. Analgesic effect of dextromethorphan for postherpetic neuralgia. Masui. 1996;45:629-633.
134. Pud D, Eisenberg E, Spitzer A, et al. The NMDA receptor antagonist amantadine reduces surgical neuropathic pain in cancer patients: a double-blind, randomized, placebo-controlled trial. Pain. 1998;75:349-354.
135. Sang CN, Booher S, Gilron I, Parada S, Max MB. Dextromethorphan and memantine in painful diabetic neuropathy and postherpetic neuralgia: efficacy and dose-response trials. Anesthesiology. 2002;96:1053-1061.
136. Dickenson AH. NMDA receptor antagonists: interactions with opioids. Acta Anaesth Scand. 1997;41:112-115.
137. Elliott K, Kest B, Man A, Kao B, Inturrisi CE. N-Methyl-D-aspartate (NMDA) receptors, mu and kappa opioid tolerance and perspective on new analgesic drug development. Neuropsychopharmacology. 1995;13:347-356.
138. Kristensen JD, Karlsten R, Gordh T, Berge OG. The NMDA antagonist 3-(2-carboxypiperazin-4-yl) propyl-1-phosphonic acid (CPP) has antinociceptive effect after intrathecal injection in the rat. Pain. 1994;56:59-67.
139. Taverner D. Alleviation of post herpetic neuralgia. Lancet. 1960;2:671-673.
140. Nathan PD, Wall PD. Treatment of post herpetic neuralgia by prolonged electrical stimulation. BMJ. 1974;3:645-647.
141. Long DM. External electrical stimulation as a treatment of chronic pain. Minn Med. 1974;57:195-198.
142. Haas LF. Post herpetic neuralgia, treatment and prevention. Trans Ophthalmol Soc N Z. 1977;29:133-136.
143. Payne C. Ultrasound for post herpetic neuralgia. A study to investigate the results of treatment. Physiotherapy. 1984;70:96-97.
144. Lewis AT, Field J, Madim D. Acupuncture compared with placebo in post herpetic pain. Pain. 1983;17:361-368.
145. Erikson DL, Long DM. Ten years follow up of dorsal column irritation. In: Bonica JJ, Lindblom U, Iggo A, eds. Advances in Pain Research and Therapy. 5th ed. New York: Raven Press; 1983:583-590.
146. Hosobuchi Y. The current status of analgesic brain stimulation. Acta Neurichir. 1980;30:219-227.
147. Siegfried J. Monopolar electrical stimulation of nucleus ventroposteromedialis for postherpetic facial pain. Appl Neurophysiol. 1982;45:179-184.
148. Cushing H. The major trigeminal neuralgias and their surgical treatment based on experience with 332 gasserian operations. Am J Med Sci. 1920;160:157-184.
149. White JC, Sweet WH. Pain and the Neurosurgeon: A Forty Year Experience. Springfield, IL: Charles C. Thomas; 1969.
150. Tindall GT, Odom GL, Vieth RG. Surgical treatment of post-herpetic neuralgia, results of skin undermining and excision in 14 patients. Arch Neurol. 1962;7:423-426.
151. Saiki M, Kondo A, Kinuta Y, et al. Treatment of intractable postherpetic neuralgia and blepharospasm: intraneural injection of adriamycin. No Shinkei Geka. 1995;23:125-130.
152. Richter HP, Seitz K. Dorsal root entry zone lesions for the control of deafferentation pain. Experience in ten patients. Neurosurgery. 1984;15:956-959.
153. Friedman AH, Nashold BS. Dorsal root entry zone lesions for postherpetic neuralgia. Neurosurgery. 1984;70:96-97.
154. Friedman AH, Nashold BS. DREZ lesions for relief of pain related to spinal cord injury. J Neurosurg. 1986;65:465-469.
155. Gorecki JP, Nashold BS. The Duke experience with the nucleus caudalis DREZ operation. Acta Neurochir Wien. 1995;64:128-131.
156. Rath SA, Braun V, Soliman N, et al. Results of DREZ coagulations for pain related to plexus lesions, spinal cord injuries and postherpetic neuralgia. Acta Neurochir Wien. 1996;138:364-369.
157. Balfour HH. Acyclovir therapy for herpes zoster. Advantages and adverse effects (Editorial). JAMA. 1986;255:387-388.
158. McKendrick MW, McGill JI, Wood MJ. Lack of effect of acyclovir on post herpetic neuralgia. BMJ. 1989;298:431.
159. Tyring S, Barbarash RA, Nahlik JE, et al. Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1995;123:89-96.
160. Morton P, Thomson AN. Oral acyclovir in the treatment of herpes zoster in general practice. N Z Med J. 1989;102:93-95.
161. DeGreef H. Famicyclovir, a new oral antiherpes drug: results of the first controlled clinical study demonstrating its efficacy and safety in the treatment of uncomplicated herpes zoster in immunocompetent patients. Int J Antimicrobial Agents. 1995;4:241-246.
162. Esmann V, Geil JP, Kroon S, et al. Prednisolone does not prevent post-herpetic neuralgia. Lancet. 1987;2:126-129.
163. Keczkes K, Basheer AM. Do corticosteroids prevent post herpetic neuralgia? Br J Dermatol. 1980;102:551-555.
164. Clemmensen OJ, Andersen KE. ACTH versus prednisone and placebo in herpes zoster treatment. Clin Exp Dermatol. 1984;9:557-563.
165. Nakamura T, Yokoo H, Hamakawa T, et al. Preemptive analgesia produced with epidural analgesia administered prior to surgery. Masui. 1994;43:1024-1028.
166. Winnie AP, Hartwell PW. Relationship between time of treatment of acute herpes zoster with sympathetic blockade and prevention of post-herpetic neuralgia: clinical support for a new theory of the mechanism by which sympathetic blockade provides therapeutic benefit. Reg Anesth. 1993;18:277-282.
167. Ali NM. Does sympathetic ganglionic block prevent postherpetic neuralgia? Literature review. Reg Anesth. 1995;20:227-233.
168. Niv D, Devor M. Preemptive analgesia in the relief of postoperative pain. Curr Rev Pain. 1996;1:79-92.
169. Niv D. Intraoperative treatment of postoperative pain. Pain 1996 - an updated review. In: Campbell JN, ed. IASP Refresher Course Syllabus. Seattle, WA: IASP Press; 1996:173-187.